Literature DB >> 1248672

Interaction of somatostatin, glucagon, and insulin on hepatic glucose output in the normal dog.

N Altszuler, B Gottlieb, J Hampshire.   

Abstract

The interaction of insulin and glucagon during infusion of somatostatin (SRIF), which suppresses secretion of these hormones, was investigated in normal, postabsorptive, concious dogs. Hepatic glucose output (production) and over-all glucose uptake by the tissues was measured with 3-3H-glucose, administered by a priming injection along with a constant infusion. Infusion of SRIF (1.5-5.0 mug/min) for 90 minutes resulted in a moderate hypoglycemia associated with a decrease in glucose production. In some animals glucose production and plasma glucose levels returned to normal before the end of SRIF infusion. Glucose uptake tended to follow plasma glucose levels. Upon termination of SRIF infusion, glucose production and uptake and plasma glucose increased sharply.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1248672     DOI: 10.2337/diab.25.2.116

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  12 in total

1.  Combined effects of cold and somatostatin on glucose kinetics in dogs.

Authors:  Y Minaire; J Forichon; G Dallevet; M J Jomain
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1981

2.  Somatostatin infusion in liver cirrhosis: glucagon control of glucose homeostasis.

Authors:  A V Greco; L Altomonte; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

3.  Effect of somatostatin (SRIF) on plasma glucose and insulin response to glucagon in liver cirrhosis.

Authors:  L Altomonte; A V Greco; G Ghirlanda; A G Rebuzzi; R Manna; A Bertoli
Journal:  Acta Diabetol Lat       Date:  1979 Apr-Jun

4.  Effect of glucagon on glucose production during insulin deficiency in the dog.

Authors:  A D Cherrington; W W Lacy; J L Chiasson
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

5.  Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.

Authors:  J E Liljenquist; G L Mueller; A D Cherrington; U Keller; J M Perry; W W Lacy; D Rabinowitz
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

6.  Influence of somatostatin on splanchnic glucose metabolism in postabsorptive and 60-hour fasted humans.

Authors:  J Wahren; S Efendić; R Luft; L Hagenfeldt; O Björkman; P Felig
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

7.  The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog.

Authors:  A D Cherrington; J L Chiasson; J E Liljenquist; A S Jennings; U Keller; W W Lacy
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

8.  Effect of somatostatin-induced insulinopenia on glucose oxidation in man.

Authors:  J P Felber; D Thiébaud; E Maeder; E Jéquier; R Hendler; R A DeFronzo
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

9.  Metabolic intervention in surgical patients. An assessment of the effect of somatostatin, ranitidine, naloxone, diclophenac, dipyridamole, or salbutamol infusion on energy and protein kinetics in surgical patients using stable and radioisotopes.

Authors:  J H Shaw; R R Wolfe
Journal:  Ann Surg       Date:  1988-03       Impact factor: 12.969

10.  Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin.

Authors:  R S Sherwin; R Hendler; R DeFronzo; J Wahren; P Felic
Journal:  Proc Natl Acad Sci U S A       Date:  1977-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.